It's estimated that close to 60% of people with HIV in the US or Europe use at least one of Gilead's four HIV drugs. For new patients, that number may reach 80%. The increased sales have ...

Gilead Sciences, US government settle patent case over HIV prevention drugs Legalcategory· January 15, 2025 Gilead Sciences said on Saturday that it entered into a partnership with Denmark's LEO ...